Clinical Trial Update: Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria

View source ↗

Summary

A completed study evaluating the effectiveness and safety of artemether-lumefantrine for malaria has reported its surveillance results. The sponsor is Novartis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Coartem (artemether-lumefantrine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Malaria | Status: COMPLETED